Unprecedented Growth & Future Job Opportunity BIOTECHNOLOGY Dr. Sanjiv Kumar Maheshwari Professor and Dean, IFTM University, Moradabad

Biotechnology  Market and Growth Potential  Players  Opportunities  Why India

Courses offered by School of Biotechnology, IFTM University S No Course Duration (Years) Fee Per semester (RS.) Eligibility 1B. Tech. (Biotechnology)445000Minimum 45% (40% for SC/ST) at 10+2 with Physics, Chemistry, Mathematics / Biology 2B. Sc. (Biotechnology/Microbiology /Food Technology) Minimum 45% (40% for SC/ST) at 10+2 with Physics, Chemistry, Mathematics / Biology 3M. Sc. (Biotechnology/Microbiology /Food Technology) Minimum 50% (45% for SC/ST) at B.Sc. (Biotech.) / related Life Sciences 4M. Tech. (Biotechnology)241000Minimum 55% at B. Tech. (Biotechnology) 5Ph. D. (Biotechnology)230000As per latest UGC Norms

Biotech Market - Dynamic and growing  Size ( ) US$ mn  Largest segment Biopharma not to be confused with Pharma  Revenue from exports ( ) 56%  Total investment( ) US$ 137 million Rate of growth over %  Size ( ) US$ 4 Bn  Growth of Sector ( ) over 50% US$ 1 BN= 634 Crore

Bio Agri 6.95% Bio Pharma % Bio Services 8.95% Bio-IT 2.09 % Biopharma leads the way Composition of Indian Biotech Sector ( ) Bio Industrial 6.74% Source:Biospectrum-ABLE Survey

Biotechnology as a Sector Third Largest Biotech Industry in Asia Pacific Region. Second Highest number of USFDA approved plants. US$ 3.7 BN to be spent on Biotechnology in India from No. 1 producer of Hepatitis B Vaccine. US$ 4.3 BN Bioeconomy (earning from Biotechnology) by the end of 2015 US$ 200 BN Industry by US$ 1 BN= 634 Crore (Source: Make in India)

Market - A consistent uptrend % growth in investment 70% growth in employment 74% growth in R&D manpower 10% of global industry 1 million skilled jobs US$ 5 billion annual revenues Source: Confederation of Indian Industry (CII)

Indian Players

MNCs Scripting Success in India

Top MNCs World Wide RankCompanyCountry Market Cap in Q (USD billion Market Cap in 2014 (USD billions 1Johnson & JohnsonUSA NovartisSwitzerland RocheSwitzerland PfizerUSA MerckUSA Novo NordiskDEN Gilead SciencesUSA SanofiFRA AmgenUSA ActavisUSA GlaxoSmithKlineGBR Bristol-Myers SquibbUSA Biogen IdecUSA AbbVieUSA CelgeneUSA AstraZenecaGBR Eli Lilly & CoUSA Abbott LaboratoriesUSA Valeant PharmaceuticalsCAN Teva PharmaceuticalISR

India: The Vaccine Hub Indian firms estimated to supply 90% of global demand for the measles vaccine, in the near future. Serum Institute, Pune is believed to be the world`s largest manufacturer of DPT vaccines. Indian Immunologicals operates the world`s second largest plant for veterinary vaccines and is also the world`s largest manufacturer of the vaccine against Foot and Mouth Disease.

Invest in Agri Biotech Biofertilisers GM Crops and seeds Biopesticides Biofuels Ag. Biotechnology

The India Advantage Trained manpower and knowledge base Rich biodiversity Extensive clinical trials opportunities Excellent network of research laboratories Well-developed base industries

The R & D Advantage Genetic Engineering DNA technologies New Drug Delivery Systems Rational drug design Stem cell research Bioinformatics Biotech R&D strengths spread across range of segments